Elicio Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Elicio Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q3 2024.
  • Elicio Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 210 %, a 39.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 210 -139 -39.8% Sep 30, 2024
Q2 2024 164 -380 -69.8% Jun 30, 2024
Q1 2024 220 -479 -68.5% Mar 31, 2024
Q4 2023 334 -297 -47% Dec 31, 2023
Q3 2023 348 -422 -54.8% Sep 30, 2023
Q2 2023 544 -169 -23.7% Jun 30, 2023
Q1 2023 700 +48.5 +7.45% Mar 31, 2023
Q4 2022 631 -41.8 -6.21% Dec 31, 2022
Q3 2022 771 +525 +214% Sep 30, 2022
Q2 2022 713 Jun 30, 2022
Q1 2022 651 Mar 31, 2022
Q4 2021 673 Dec 31, 2021
Q3 2021 246 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.